(Clinical Chemistry. 1998;44:1072.)
© 1998 American Association for Clinical Chemistry, Inc.
Standards of laboratory practice: guidelines for the maintaining of a modern therapeutic drug monitoring service
Lawrence A. Kaplan
Department of Pathology, New York University Medical Center, Bellevue Hospital, First Avenue & 27th Street, New York, NY 10016. Fax 212-263-8284; e-mail kaplan@is2.nyu.edu.
 |
Introduction
|
|---|
On Saturday, June 19, 1997 the National Academy of Clinical Biochemistry
held a meeting to publicly review a draft document containing
recommendations on the provision of basic therapeutic drug monitoring
(TDM) services. This was the third in a continuing series of meetings
on Standards of Laboratory Practice (SOLP), which was established to
provide practice guidelines for laboratory scientists in a focused area
of laboratory medicine. The manuscripts and summaries of two earlier
SOLPs, on Thyroid Disease (1) and on Support of the Newborn
(2), were published in this Journal, and the monographs are
available from the NACB.
By facilitating discussion between clinical laboratory analysts . . . [Full Text of this Article]
 |
References
|
|---|
The following articles in journals at HighWire Press have cited this article:

|
 |

|
 |
 
J. M. Juenke, P. I. Brown, F. M. Urry, and G. A. McMillin
Specimen Dilution for C2 Monitoring with the Abbott TDxFLx Cyclosporine Monoclonal Whole Blood Assay
Clin. Chem.,
August 1, 2004;
50(8):
1430 - 1433.
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Association for Clinical Chemistry.